Bruker Corporation (BRKR)
| Previous close | 64.93 |
| Open | 64.75 |
| Bid | 64.85 x 400 |
| Ask | 65.00 x 100 |
| Day's range | 64.41 - 65.76 |
| 52-week range | 53.79 - 94.86 |
| Volume | |
| Avg. volume | 1,173,672 |
| Market cap | 9.831B |
| Beta (5Y monthly) | 1.25 |
| PE ratio (TTM) | 23.79 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.20 (0.31%) |
| Ex-dividend date | 03 Jun 2024 |
| 1y target est | N/A |
- Business Wire
Bruker Launches Ultimate Sensitivity timsTOF Ultra 2 to Enable New Research Paradigms in Single-Cell and Subcellular Proteomics
ANAHEIM, Calif., June 03, 2024--At the 72nd ASMS meeting, Bruker Corporation (Nasdaq: BRKR) launches the new top-of-the-line timsTOF Ultra 2 system with significantly further enhanced sensitivity for deep profiling of small cells, subcellular organelles, as well as increased sample loading flexibility. Together with new Spectronaut 19 software and the novel PreOmics ENRICHplus kit, Bruker is setting new 4D-Proteomics standards from highest sensitivity to large-scale, deep plasma proteomics. Bruk
- Business Wire
Bruker Applied Mass Spectrometry Division Showcases High-Performance Solutions for Research and Analysis in Applied Laboratories
ANAHEIM, Calif., June 03, 2024--The Bruker Applied Mass Spectrometry Division is showcasing some of its latest innovations at ASMS 2024:
- Business Wire
Bruker Launches Transformative neofleX™ MALDI-TOF System for Spatial Biology Mass Spec Imaging (MSI) Applications
ANAHEIM, Calif., June 03, 2024--At the 72nd ASMS meeting, Bruker Corporation (Nasdaq: BRKR) announced the launch of a novel, high-performance MALDI-TOF/TOF system, the neofleX Imaging Profiler for mass spectrometry-based tissue imaging. It enables facile OME-TIFF file output via the new SCiLS Scope software. The transformative neofleX MALDI-TOF/TOF MSI system now conveniently fits on a bench-top.
